CASE STUDY: A Married Couple Dealing with Alzheimer’s Disease
Sheila Alvarez
The Praxis Institute
OTA 100/101
Professor Judith Miller
08/09/2021
A Married Couple Dealing with Alzheimer’s Disease
Alzheimer’s is everything except a common piece of development. The best-acknowledged peril factor is extending age, and most people with Alzheimer’s are 60 and more settled. Alzheimer’s affliction is seen as more energetic starting Alzheimer’s if it impacts a person under 65. The more young start can similarly be insinuated as early-phase Alzheimer’s. People with more young starting Alzheimer’s can be in the early, focus, or late period of the ailment. The most broadly perceived early indication of Alzheimer’s is inconvenience remembering as of late instructed information. As a matter of fact, like the rest of our bodies, our frontal cortexes change as we age. An enormous bit of us over the long haul notice some moved back thinking and irregular issues with reviewing certain things. In any case, certifiable psychological decay, chaos, and other huge changes in the way in which our minds work may be a sign that neurotransmitters are missing the mark. People with other possible signs of Alzheimer’s strength imagine that it is hard to recollect that they have an issue. Signs of dementia may be all the more obvious to family members or mates. Anyone experiencing dementia-like signs ought to consider a to be immediate. If you need assistance finding an expert with experience surveying memory issues, your close by Alzheimer’s Association can help. Earlier finding and intervention procedures are improving altogether, and treatment options and wellsprings assist with canning work on close-to-home fulfillment. To inspect Alzheimer’s dementia, specialists lead tests to evaluate memory insufficiency and other reasoning limits, judge supportive cutoff points, and see direct changes. They likewise play out the development of tests to hinder other potential purposes behind impedance. (Chami, 2021).
The danger of developing Alzheimer’s or vascular dementia has all of the stores being stretched out by different conditions that hurt the heart and veins. This breaker coronary affliction, diabetes, stroke, hypertension, and raised cholesterol. Alzheimer’s affliction is a reformist neurologic issue that makes the mind pull out (decay) and synapses flop wretchedly. Alzheimer’s defilement is the most extensively seen dementia support a determined reduction in reasoning, administration, and social limits that impacts an individual’s capacity to work self-rulingly. (Gentile, 2013).
Drugs for the treatment of Alzheimer’s sickness that are accessible today incorporate cholinesterase inhibitors and the NMDA-receptor adversary, memantine. These medications are protected and in a few huge and free investigations, they were accounted for to create moderate suggestive advantages. The specific neurological explanation individuals living with dementia quit talking will be distinctive for every individual. For certain individuals, the piece of the cerebrum that controls discourse might be harmed from vascular occasions. For other people, the plaques and tangles related to Alzheimer’s infection might upset correspondence. Aducanumab is the solitary sickness-changing medicine at present supported to treat Alzheimer’s. (Waldemar, & Burns, 2017). This prescription is a human immunizer, or immunotherapy, that objectives the protein beta-amyloid and assists with decreasing amyloid plaques, which are mind injuries related to Alzheimer’s. Be that as it may, the cognitive decline related to Alzheimer’s sickness deteriorates over the long haul, in the end influencing an individual’s capacity to work or perform day-by-day exercises. Alongside trouble thinking or focusing, Alzheimer’s might cause crabbiness, state of mind swings, and episodes of outrage, uneasiness, and dread.
As of now, in any case, there is no treatment accessible that can stop the reformist weakening of intellectual capacities in Alzheimer’s sickness patients. The advancement of novel medications with solid sickness adjusting properties accordingly addresses one of the greatest neglected clinical requirements today. (Richter, & Richter, 2013). The pathophysiology of Alzheimer’s infection and the quest for novel remedial methodologies have been a significant focal point of scholastic and industry research for quite a while. The dominating theory to clarify the pathogenesis is the amyloid course speculation, and therefore, a few of the novel and promising remedial techniques are explicitly tending to the amyloid pathology. Regardless of whether against A?-immunotherapy, little particle secretase inhibitors, other A? bringing down approaches or collection inhibitors will end up being protected and will want to stop or hinder sickness movement stays not yet clear. ( Schaber, 2010).
Meds that focus on the fundamental reasons for infection are called sickness changing medications or treatments. Aducanumab is the solitary sickness altering prescription at present supported to treat Alzheimer’s. This drug is a human counter-acting agent, or immunotherapy, that objectives the protein beta-amyloid and assists with decreasing amyloid plaques, which are cerebrum injuries related to Alzheimer’s. Clinical investigations to decide the adequacy of aducanumab were directed distinctly in individuals with beginning phase Alzheimer’s or gentle psychological disability. Analysts are proceeding to contemplate whether this medicine attempts to influence an individual’s pace of intellectual decay over the long haul. Before recommending aducanumab, specialists might require PET outputs or an investigation of cerebrospinal liquid to assess whether amyloid stores are available in the cerebrum. This can help specialists make a precise analysis of Alzheimer’s before endorsing the medicine. When an individual is on aducanumab, their PCP or expert might require routine MRIs to screen for incidental effects, for example, mind growing or draining in the cerebrum. A few other sicknesses changing drugs are being tried in individuals with a gentle intellectual disability or early Alzheimer’s as expected therapies.
A medication known as memantine, an N-methyl D-aspartate (NMDA) foe, is supported to get moderate genuine Alzheimer’s contamination. This current medicine’s central effect is to lessen appearances, which could engage a couple of gathering to stay aware of certain consistent limits to some degree more than they would without the medication. For example, memantine may help a person in the later periods of the ailment stay aware of their ability to use the washroom openly for a couple of extra months, a benefit for both the person with Alzheimer’s and watchmen. Memantine is acknowledged to work by overseeing glutamate, a huge brain compound. Exactly when made in over-the-top totals, glutamate may incite neurotransmitter destruction. Since NMDA adversaries work particularly rather than cholinesterase inhibitors, the two sorts of meds can be supported in the blend. The FDA has similarly upheld donepezil, the rivastigmine fix, and a mixed remedy of memantine and donepezil for the treatment of moderate to outrageous Alzheimer’s. ( Jha, & Mukhopadhaya, 2020).
Worldwide, something like 50 million individuals is accepted to be living with Alzheimer’s sickness or different dementias. As indicated by the United Nations, that is more than the number of inhabitants in Columbia. In case forward leaps are not found, rates could surpass 152 million by 2050. . The primary danger factors for fostering Alzheimer’s illness (AD) are age and sex. The rate of sickness is higher in ladies than in men, and this can’t just be credited to the higher life span of ladies versus men. In the vast majority with Alzheimer’s illness, side effects initially show up after age 60. Around 3% of people, ages 65 to 74 have the sickness, however almost 50% of those age 85 and more established may have the illness. The normal age at analysis is around 80. No drugs are unequivocally supported by the FDA to treat social and mental signs that may make in the moderate and genuine periods of Alzheimer’s dementia. In case nonpharmacologic treatment isn’t compelling moreover, these appearances can make hurt the individual or others, specialists may suggest drugs upheld for relative signs in people with different conditions. A kind of prescription called antipsychotics may be prescribed to treat dreams, antagonism, and agitating. Regardless, research has shown that a couple of antipsychotics are connected with an extended risk of stroke and downfall in individuals with dementia.49-50 The decision to use antipsychotics ought to be considered with ludicrous alarm. The FDA has mentioned creators to name such drugs with a “revelation notice” about their risks and an update that they are not embraced to treat dementia incidental effects. Various factors add to the difficulty of making reasonable medications for Alzheimer’s. These consolidate the drowsy speed of choosing sufficient amounts of individuals and enough varying individuals to clinical examinations, openings in data about the specific nuclear changes and natural cycles in the brain that cause Alzheimer’s ailment, and the by and large significant time-frame expected to see whether an investigational treatment impacts disease development. Likewise, since mixed dementia is so typical, impressively more frontal cortex changes than as of late suspected maybe adding to indications, further trapping decisions about which frontal cortex changes to the target.
OT assists individuals with Alzheimer’s illness and their parental figures to carry on with life to its fullest by adjusting the climate and zeroing in on how they can deal with expanding commitment in action (occupation), advancing wellbeing, and improve personal satisfaction. OT will work with somebody with dementia to distinguish where there are troubles in autonomous capacity and everyday exercises. They’ll prescribe approaches to adjust the climate to help the individual with dementia, for instance by adding dementia-accommodating timekeepers or by marking entryways. (Schaber, 2010).
An OT will work with a customer with Alzheimer’s to recognize the regions they are battling with and help them discover ways around these. We expect to give down-to-earth exhortations and methods straightforwardly to the customer just as their family members. Occupational specialists center around working with you and your family to adapt to the progressions that the sickness brings and make life as full as could be expected. Peruse more about how word-related treatment can assist your cherished one with Alzheimer’s.OTs will work with the relatives and the individual with the infection to survey the home climate and home security. An OT makes proposals for what necessities to change to protect the individual too as what gear can be utilized for everyday exercises to lessen the opportunity of injury. OTs likewise give direction on the best way to make day-by-day exercises simpler.
OT is talented in assessing all parts of the space, their interrelationships, and the customer inside their specific situations and conditions. Also, word-related treatment experts perceive the significance and effect of the brain-bodysoul association as the customer partakes in everyday life. Information of the value-based relationship and the meaning of significant and useful occupations structure the premise for the utilization of occupations as both the means and the finishes of intercessions. This information sets word-related treatment separated as particular and important assistance for which attention on the entire is considered more grounded than attention on segregated parts of human capacity.
The client Mr. Johnson displayed no evidence of apraxia. It was difficult for the family to read his emotions because of the facial masking that he had. The executive skills o Mr. Johnson had been impaired. He also needs help in verbal assistance. The wife, Mrs. Johnson was taught by the OT to deliver cognitive support to her husband, Mr. Johnson. Mrs. Johnson was the primary caregiver and had the aim and goal of maintaining a purposeful relationship with her husband.
The long-term goal for Mr. Johnson is to regain and improve his memory. A memory book was created for the client to help him remember people and important events that had happened in the past. Mr. Johnson loves bird watching, a special section of birds was included so that he can continue watching the birds. The short-term goal is to increase his attention and be present in the moment. ( Fisher, Hanin, & Lachman, 2012).
Evaluation
Intervention
Outcomes
Mr. Johnson is a 63-year-old who had been having difficulty with the family. He often misplaces things and forgets often. Mr. Johnson was diagnosed with Alzheimers disease.
Some strategies were suggested by the Occupation Therapist after the assessment and interview of Mr. Johnson. Mrs. Johnson her wife, was taught to deliver cognitive support to Mr. Johnson. The client mostly required verbal cues. He needed help in getting started.
The family of the client was introduced to a cueing strategy t help, Mr. Johnson. Since the client displayed some facial masking and it was difficult to read his emotions, his family was introduced to neurological deficits
A message center was built in the home and it was found that Mr. Johnson would be able to perform simple tasks. When guided verbally, he could do most of the tasks. Mr. Johnson can dress when his clothes are placed in the same order each day.
References
Burke, A., Hall, G. R., Yaari, R., Fleisher, A., Dougherty, J., Young, J., Brand, H., & Tariot, P. (2015). Pocket reference to Alzheimer’s disease management. Springer.
Chami, M. (2021). Calcium signaling in Alzheimers disease: From Pathophysiological regulation to therapeutic approaches. MDPI.
Fisher, A., Hanin, I., & Lachman, C. (2012). Alzheimers disease: Problems, prospects, and perspectives. Springer.
Gentile, R. (2013). Possible therapeutic approaches for the treatment of Alzheimer?s disease.
Jha, A., & Mukhopadhaya, K. (2020). Alzheimers disease: Diagnosis and treatment guide. Springer Nature.
McMahon, J. M. (2009). Occupational therapy intervention for people with early-stage Alzheimer’s disease.
Meyer, E. (2013). Novel approaches to the treatment of Alzheimers disease. Springer Science & Business Media.
Piersol, C. V., & Jensen, L. (2017). Occupational therapy practice guidelines for adults with Alzheimer’s disease and related major neurocognitive disorders.
Richter, R. W., & Richter, B. Z. (2013). Alzheimers disease: A physicians guide to practical management. Humana Press.
Schaber, P. (2010). undefined. American Occupational Therapy Association.
Waldemar, G., & Burns, A. (2017). undefined. Oxford University Press.
